加拿大养殖水貂接种SARS-CoV-2疫苗后抗体应答调查
研究检测加拿大50只养殖水貂接种猫用商业Index刺突蛋白疫苗后的抗体应答,ELISA滴度最高达1:12800,对祖先D614G株和Omicron BA.4株均产生高水平交叉中和抗体,且抗体水平显著高于丹麦感染水貂,与再感染后回忆应答相当。
要点
- 水貂接种猫用Index刺突蛋白疫苗后ELISA抗体滴度最高达1:12800。
- 疫苗诱导对祖先D614G株和Omicron BA.4株的高水平交叉中和抗体。
- 加拿大接种水貂抗体水平显著高于丹麦近期感染水貂,与再感染后回忆应答相当。
核心结论
- 加拿大养殖水貂所用疫苗能在水貂中诱导强烈且广谱反应的抗体应答,可能限制SARS-CoV-2在养殖水貂中的传播,从而降低水貂作为人类感染SARS-CoV-2储存宿主的风险。
研究设计与样本
- 研究从加拿大达尔豪斯大学Truro校区的加拿大毛皮动物研究中心(CCFAR)采集50只水貂血样。
- 水貂接种了获批用于猫的商业Index刺突蛋白疫苗。
- 血清先经酶联免疫吸附试验(ELISA)检测抗体,部分血清随后进行病毒中和试验。
- 中和抗体水平针对祖先D614G株和近期流行Omicron BA.4变异株评估。
- 抗体应答与丹麦养殖水貂感染后观察到的应答进行比较。
主要发现
- 疫苗诱导水貂强烈抗体应答,ELISA抗体滴度最高达1:12800。
- 接种水貂获得高水平中和抗体,尽管祖先株与Omicron BA.4株遗传差异大,仍显示高水平交叉反应中和抗体。
- 加拿大接种水貂SARS-CoV-2抗体水平显著高于近期感染的丹麦水貂,与再感染后回忆应答相当。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Currently, SARS-CoV-2 have been detected in farmed mink in 13 different countries. Due to the high susceptibility and transmissibility among mink, great concerns of mink serving as a reservoir to generate novel variants with unknown virulence and antigenic properties arose. These concerns have consequently resulted in entire mink productions being culled and banned. This study investigates the post-vaccination antibody response in the Canadian farmed mink vaccinated with a commercial Index spike protein-based vaccine, approved for use in cats, and compares the antibody response to that observed post infection in Danish farmed mink. Blood samples were obtained from 50 mink at the Canadian Centre for Fur Animal Research (CCFAR), Dalhousie University (Truro, Canada). The sera were initially analyzed for antibodies by enzyme-linked immunosorbent assay (ELISA), and selected sera was subsequently tested in a virus neutralization tests. The levels of neutralizing antibodies were evaluated for an ancestral D614G strain and a recent circulating SARS-CoV-2 variant of concern (Omicron BA.4). The results revealed that the vaccine induced a strong antibody response in mink by reaching antibody titer levels of up to 1:12800 in the ELISA. Moreover, high levels of neutralizing antibodies were obtained, and despite the great level of genetic differences between the ancestral and Omicron BA.4 strains, the vaccinated mink showed high levels of cross-reacting neutralizing antibodies. Interestingly, the antibody levels towards SARS-CoV-2 in the Canadian vaccinated mink were significantly higher than observed in recently SARS-CoV-2 infected Danish mink and equal to anamnestic responses following re-infection. In conclusion, the vaccine used in the Canadian farmed mink was able to induce a strong and broad-reacting antibody response in mink, which could limit the spread of SARS-CoV-2 in farmed mink and thereby reduce the risk of mink serving as a SARS-CoV-2 reservoir for human infections.
引用
- Hansen LG, Larsen LE, Rasmussen TB, et al. Investigation of the SARS-CoV-2 post-vaccination antibody response in Canadian farmed mink. Vaccine. 2023. PMID: 37932134. doi:10.1016/j.vaccine.2023.10.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。